A Role for the Nucleosome Assembly Proteins TAF-Iβ and NAP1 in the Activation of BZLF1 Expression and Epstein-Barr Virus Reactivation

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Mansouri, Sheila ^a   Wang, Shan ^a   Frappier, Lori ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; HISTONE H3; HISTONE H4; IMMEDIATE EARLY PROTEIN BZLF1; MIXED LINEAGE LEUKEMIA PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN 1; NUCLEOSOME ASSEMBLY PROTEIN 1; TEMPLATE ACTIVATING FACTOR IBETA; UNCLASSIFIED DRUG;

ARTICLE; CHROMATIN; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; LYSIS; NONHUMAN; PROMOTER REGION; PROTEIN FUNCTION; VIRUS REACTIVATION;

ACETYLATION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HISTONE CHAPERONES; HISTONES; HUMANS; METHYLATION; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NUCLEOSOMES; PROMOTER REGIONS, GENETIC; PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; VIRUS ACTIVATION;

EID: 84877738439     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063802     Document Type: Article

References (53)

1. Adams A, (1987) Replication of latent Epstein-Barr virus genomes. J Virol 61: 1743-1746.
2. Kieff E, Rickinson AB (2001) Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott Williams and Wilkins. 2511-2573.
3. Liu S, Borras AM, Liu P, Suske G, Speck SH, (1997) Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. Virology 228: 11-18.
4. Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L, (2007) Lytic cycle switches of oncogenic human gammaherpesviruses(1). Adv Cancer Res 97: 81-109.
5. Lieberman PM, Hardwick JM, Sample J, Hayward GS, Hayward SD, (1990) The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. J Virol 64: 1143-1155.
6. Speck SH, Chatila T, Flemington E, (1997) Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol 5: 399-405.
7. Feederle R, Kost M, Baumann M, Janz A, Drouet E, et al. (2000) The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. Embo J 19: 3080-3089.
8. Fixman ED, Hayward GS, Hayward SD, (1992) trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J Virol 66: 5030-5039.
9. Gao Z, Krithivas A, Finan JE, Semmes OJ, Zhou S, et al. (1998) The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins. J Virol 72: 8559-8567.
10. Schepers A, Pich D, Mankertz J, Hammerschmidt W, (1993) cis-Acting elements in the lytic origin of DNA replication of Epstein-Barr virus. J Virol 67: 4237-4245.
11. Wu FY, Wang SE, Chen H, Wang L, Hayward SD, et al. (2004) CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle. J Virol 78: 4847-4865.
12. Feng WH, Kraus RJ, Dickerson SJ, Lim HJ, Jones RJ, et al. (2007) ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells. J Virol 81: 10113-10122.
13. Huang J, Liao G, Chen H, Wu FY, Hutt-Fletcher L, et al. (2006) Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells. J Virol 80: 1098-1109.
14. Yu X, Wang Z, Mertz JE, (2007) ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus. PLoS Pathog 3: e194.
15. Dyson PJ, Farrell PJ, (1985) Chromatin structure of Epstein-Barr virus. J Gen Virol 66 (Pt 9): 1931-1940.
16. Shaw J, Levinger L, Carter C, (1979) Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines. J Virol 29: 657-665.
17. Countryman JK, Gradoville L, Miller G, (2008) Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. J Virol 82: 4706-4719.
18. Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L, (2007) Lytic cycle switches of oncogenic human gammaherpesviruses. Adv Cancer Res 97: 81-109.
19. Jenkins PJ, Binne UK, Farrell PJ, (2000) Histone acetylation and reactivation of Epstein-Barr virus from latency. J Virol 74: 710-720.
20. Wang S, Frappier L, (2009) Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation. J Virol 83: 11704-11714.
21. Lin A, Wang S, Nguyen T, Shire K, Frappier L, (2008) The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4. J Virol 82: 12009-12019.
22. Holowaty MN, Zeghouf M, Wu H, Tellam J, Athanasopoulos V, et al. (2003) Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J Biol Chem 278: 29987-29994.
23. Matsumoto K, Nagata K, Ui M, Hanaoka F, (1993) Template activating factor I, a novel host factor required to stimulate the adenovirus core DNA replication. J Biol Chem 268: 10582-10587.
24. Nagata K, Kawase H, Handa H, Yano K, Yamasaki M, et al. (1995) Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis. Proc Natl Acad Sci 92: 4279-4283.
25. Miyamoto S, Suzuki T, Muto S, Aizawa K, Kimura A, et al. (2003) Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain. Mol Cell Biol 23: 8528-8541.
26. Seo SB, McNamara P, Heo S, Turner A, Lane WS, et al. (2001) Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell 104: 119-130.
27. Karetsou Z, Martic G, Sflomos G, Papamarcaki T, (2005) The histone chaperone SET/TAF-Ibeta interacts functionally with the CREB-binding protein. Biochem Biophys Res Commun 335: 322-327.
28. Shikama N, Chan HM, Krstic-Demonacos M, Smith L, Lee CW, et al. (2000) Functional interaction between nucleosome assembly proteins and p300/CREB-binding protein family coactivators. Mol Cell Biol 20: 8933-8943.
29. Wen W, Iwakiri D, Yamamoto K, Maruo S, Kanda T, et al. (2007) Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J Virol 81: 1037-1042.
30. Zhou J, Snyder AR, Lieberman PM, (2009) Epstein-Barr virus episome stability is coupled to a delay in replication timing. J Virol 83: 2154-2162.
31. Deng Z, Atanasiu C, Zhao K, Marmorstein R, Sbodio JI, et al. (2005) Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1. J Virol 79: 4640-4650.
32. Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, et al. (2002) MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell 10: 1107-1117.
33. Dou Y, Milne TA, Tackett AJ, Smith ER, Fukuda A, et al. (2005) Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell 121: 873-885.
34. Patel A, Dharmarajan V, Vought VE, Cosgrove MS, (2009) On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex. J Biol Chem 284: 24242-24256.
35. Adler HT, Nallaseth FS, Walter G, Tkachuk DC, (1997) HRX leukemic fusion proteins form a heterocomplex with the leukemia-associated protein SET and protein phosphatase 2A. J Biol Chem 272: 28407-28414.
36. Shimoyama T, Kato K, Miyaji-Yamaguchi M, Nagata K, (2005) Synergistic action of MLL, a TRX protein with template activating factor-I, a histone chaperone. FEBS Lett 579: 757-762.
37. Park YJ, Luger K, (2006) Structure and function of nucleosome assembly proteins. Biochem Cell Biol 84: 549-558.
38. Miyaji-Yamaguchi M, Okuwaki M, Nagata K, (1999) Coiled-coil structure-mediated dimerization of template activating factor-I is critical for its chromatin remodeling activity. J Mol Biol 290: 547-557.
39. Kawase H, Okuwaki M, Miyaji M, Ohba R, Handa H, et al. (1996) NAP-1 is a functional homologue of TAF-I that is required for replication and transcription of the adenovirus genome in a chromatin-like structure. Genes to Cells 1: 1045-1056.
40. Narayanan A, Ruyechan WT, Kristie TM, (2007) The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection. Proc Natl Acad Sci U S A 104: 10835-10840.
41. Sivachandran N, Wang X, Frappier L, (2012) Functions of the Epstein-Barr Virus EBNA1 Protein in Viral Reactivation and Lytic Infection. J Virol 86: 6146-6158.
42. Thorley-Lawson DA, Miyashita EM, Khan G, (1996) Epstein-Barr virus and the B cell: that's all it takes. Trends in Microbiology 4: 204-208.
43. Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA, (2009) The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 5: e1000496.
44. Borza CM, Hutt-Fletcher LM, (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8: 594-599.
45. Hutt-Fletcher LM, (2007) Epstein-Barr virus entry. J Virol 81: 7825-7832.
46. Tsao SW, Tsang CM, Pang PS, Zhang G, Chen H, et al. (2012) The biology of EBV infection in human epithelial cells. Semin Cancer Biol 22: 137-143.
47. Amon W, Farrell PJ, (2005) Reactivation of Epstein-Barr virus from latency. Rev Med Virol 15: 149-156.
48. Feng WH, Israel B, Raab-Traub N, Busson P, Kenney SC, (2002) Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. Cancer Res 62: 1920-1926.
49. Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, et al. (1989) Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci U S A 86: 9524-9528.
50. Sarkari F, Wang X, Nguyen T, Frappier L, (2011) The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies. PLoS ONE 6: e16598.
51. Diehl F, Rossig L, Zeiher AM, Dimmeler S, Urbich C, (2007) The histone methyltransferase MLL is an upstream regulator of endothelial-cell sprout formation. Blood 109: 1472-1478.
52. Ishimi Y, Sato W, Kojima M, Sugasawa K, Hanaoka F, et al. (1985) Rapid purification of nucleosome assembly protein (AP-I) and production of monoclonal antibodies against it. Cell Struct Funct 10: 373-382.
53. Yuan J, Cahir-McFarland E, Zhao B, Kieff E, (2006) Virus and cell RNAs expressed during Epstein-Barr virus replication. J Virol 80: 2548-2565.